The Mitochondrial Revolution: New Hope for Chronic Fatigue Patients
In a groundbreaking presentation at the IACFS/ME Conference, pharmaceutical researcher Dr. Sundeep Dugar revealed how decades of mitochondrial research may finally solve one of Chronic Fatigue Syndrome’s (ME/CFS) most challenging paradoxes: patients need exercise to improve mitochondrial function, but exercise itself triggers debilitating post-exertional malaise (PEM). This tiredness factor triggers lifestyle changes in even the most resilient.
The Energy Crisis
Mitochondria exist in nearly every cell of your body, producing approximately 90-95% of your energy currency: ATP. The scale is remarkable, each person produces their body weight in ATP every single day. This energy cannot be stored; it must be manufactured continuously in every living cell.
After age 21, we naturally lose 10-15% of our mitochondria every decade. For ME/CFS patients, this creates a devastating spiral: disease stress depletes mitochondria, inability to exercise prevents regeneration, and progressive loss worsens symptoms.
The Exercise-Induced Steroid Discovery
Dr. Dugar’s lab was the first to identify this steroid in humans, finding it circulates at 17-35 micrograms per milliliter in healthy individuals.
Good ROS vs. Bad ROS
This discovery resolved a biological paradox: if ROS causes oxidative damage, why does exercise, which produces ROS, improve health?
The answer lies in the “beneficial zone.” The right amount of ROS triggers adaptive responses including mitochondrial biogenesis and enhanced antioxidant defenses. Too little provides no signal. Too much causes cellular damage.
ME/CFS patients may be stuck in the “too much” category, with excessive ROS from pathological stress damaging mitochondria without the ability to exercise and harness ROS beneficially.
A Unifying Framework for ME/CFS
Dr. Dugar proposed a paradigm shift in understanding ME/CFS. Rather than viewing diverse symptoms, neurological issues, muscle dysfunction, pain sensitivity, cognitive impairment, as separate pathways, he suggests central mitochondrial dysfunction with varied phenotypic expressions.
“The mitochondria are in the center of it, and these are simply consequences that in different patients manifest differently,” he explained.
Research supports this view. Studies show ME/CFS patients have altered mitochondrial metabolism with decreased ability to fulfill cellular energy demands, leading to functional limitations and lower mitochondrial respiration.
The Exercise Conundrum
ME/CFS patients face an impossible challenge: they need exercise benefits but cannot exercise without triggering PEM, and potentially causing further damage.
“How do you calibrate your exercise that could be beneficial without tipping over into PEM?” Dr. Dugar asked. For most patients, even gentle activity can unexpectedly trigger a crash.
Enter Epicatechin
The solution lies in epicatechin, a natural compound found in green tea and cacao. Dr. Dugar’s research shows epicatechin is a structural analog of exercise-induced steroids, sharing their pharmacological properties but with 1,000-1,500 times lower potency, making it safer for supplementation.
In animal studies, epicatechin supplementation produced remarkable results:
- Exercise duration increased significantly
- Running speed improved
- Distance covered nearly doubled
- Work output increased from 377 joules to 5,000 joules
Crucially, epicatechin mimics exercise’s cellular signals without requiring physical exertion. It induces mitochondrial biogenesis, shifts fuel preference toward lipids, and triggers regenerative protein expression in muscle and neural tissue.
Human clinical studies in diabetic cardiomyopathy and Becker’s muscular dystrophy show similar improvements in muscle function, heart function, and inflammation.
Critical Considerations
Dr. Dugar emphasized two essential points:
Purity matters. Other flavonoids in green tea and cacao extracts interfere with epicatechin’s activity. Only highly purified epicatechin shows desired effects.
Dosing matters. There’s a “sweet spot”, just as you can’t exercise continuously, you can’t take unlimited epicatechin. Too much stops working due to hormetic cellular responses preventing mitochondrial excess.
A New Therapeutic Horizon
By providing exercise’s cellular signals without physical exertion, epicatechin may allow ME/CFS patients to rebuild mitochondrial capacity. As mitochondrial function improves, baseline cellular energy increases, potentially reducing PEM susceptibility and creating a positive cycle instead of the current negative spiral.
“It’s all about managing and having functional, productive mitochondria,” Dr. Dugar concluded. “Good levels of mitochondria can only help benefit clinical symptoms and clinical presentations.”
This research represents a paradigm shift from viewing ME/CFS as disparate symptoms to understanding it as central mitochondrial dysfunction—with clear therapeutic implications. While more ME/CFS-specific research is needed, the foundation is compelling: if we can’t exercise, perhaps we can still give our bodies the signals they need to heal.
Dr. Dugar’s research doesn’t offer a cure but provides something potentially more valuable: mechanistic understanding of exercise intolerance and a possible solution.
About the Speaker: Dr. Sundeep Dugar brings nearly 40 years of pharmaceutical experience, having founded four companies, co-invented Zetia and Vytorin, and dedicated 15 years to mitochondrial bioenergetics research as co-founder of BlueOakNx
2025 IACFS ME Conference Presentation
Chronic Fatigue Syndrome Myalgic Encephalomyelitis with Dr Sundeep Dugar
#MitochondrialHealth #ChronicFatigueSyndrome #BlueOakNx #Healthspan #MECFS